Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins MWG Operon, Floragenex Pen Co-marketing Agreement for RAD-seq Services

NEW YORK (GenomeWeb News) – Eurofins MWG Operon of Germany and Floragenex of Portland, Ore., will co-market their services for Restriction Site Associated DNA sequencing, or RAD-seq, the companies said today.

Under the agreement, the companies will jointly market their respective expertise in next-generation sequencing and genomic services around RAD-seq, which is used for SNP marker discovery and genotyping, particularly in genetically complex or little-characterized organisms.

Floragenex's expertise in RAD-sequencing and analysis is "a strategic fit" for Eurofins' portfolio of genomic services, said Bruno Poddevin, senior vice president of genomic services for Eurofins, in a statement, while Eurofins' experience with oligonucleotide production and its next-gen sequencing capacity are "a perfect fit for our supply chain," according to Floragenex President Rick Nipper.

Floragenex specializes in RAD-seq analyses of human, plant, and animal genomes. Eurofins MWG Operon provides a variety of genomic services. It is part of the Eurofins group, which maintains more than 160 laboratories in 32 countries.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.